Stimulation of anti-tumor immunity using dendritic cell/tumor fusions and anti-CD3/CD28.

被引：0
|
作者：
Rosenblatt, Jacalyn
Wu, Zekui
Lenahan, Corrine
Vasir, Baldev
Bissonnette, Adam
Kufe, Donald
Avigan, David
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.3715.3715
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3715
引用
收藏
页码：1061A / 1061A
页数：1
相关论文
共 50 条
  • [41] Evaluation of T Cell Proliferation Using CFSE Dilution Assay: A Comparison between Stimulation with PHA and Anti-CD3/Anti-CD28 Coated Beads
    Kashef, Sara
    Moghtaderi, Mozhgan
    Hatami, Hamid Reza
    Kalani, Mehdi
    Alyasin, Soheila
    Nabavizadeh, Hesamodin
    Farjadian, Shirin
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2022, 21 (04) : 458 - 466
  • [42] CD24 blockade promotes anti-tumor immunity in oral squamous cell carcinoma
    Zou, Ke-Long
    Lan, Zhou
    Cui, Hao
    Zhao, Yu-Yue
    Wang, Wei-Ming
    Yu, Guang-Tao
    ORAL DISEASES, 2024, 30 (02) : 163 - 171
  • [43] Immo-bile-izing CD8+T cell anti-tumor immunity
    Read, Scott A.
    Ahlenstiel, Golo
    IMMUNITY, 2025, 58 (03) : 532 - 534
  • [44] Mitochondrial metabolic flexibility is critical for CD8 T cell anti-tumor immunity
    Chen, Chao
    Qu, Cheng-Kui
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [45] Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
    Kashyap, Abhishek S.
    Thelemann, Tamara
    Klar, Richard
    Kallert, Sandra M.
    Festag, Julia
    Buchi, Melanie
    Hinterwimmer, Lisa
    Schell, Monika
    Michel, Sven
    Jaschinski, Frank
    Zippelius, Alfred
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [46] Autophagy Regulation of Metabolism Is Required for CD8+ T Cell Anti-tumor Immunity
    DeVorkin, Lindsay
    Pavey, Nils
    Carleton, Gillian
    Comber, Alexandra
    Ho, Cally
    Lim, Junghyun
    McNamara, Erin
    Huang, Haochu
    Kim, Paul
    Zacharias, Lauren G.
    Mizushima, Noboru
    Saitoh, Tatsuya
    Akira, Shizuo
    Beckham, Wayne
    Lorzadeh, Alireza
    Moksa, Michelle
    Cao, Qi
    Murthy, Aditya
    Hirst, Martin
    DeBerardinis, Ralph J.
    Lum, Julian J.
    CELL REPORTS, 2019, 27 (02): : 502 - +
  • [47] Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine
    Chang, Ming-Cheng
    Chen, Yu-Li
    Chiang, Ying-Cheng
    Cheng, Ya-Jung
    Jen, Yu-Wei
    Chen, Chi-An
    Cheng, Wen-Fang
    Sun, Wei-Zen
    AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (02): : 157 - 172
  • [48] Using anti-CD38 immunotherapy to enhance anti-tumor T-cell immunity in chronic lymphocytic leukemia (CLL)
    Manna, Alak
    Lewis-Tuffin, Laura J.
    Ailawadhi, Sikander
    Chanan-Khan, Asher A.
    Paulus, Aneel
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [49] Anti-tumor immunity and tumor anti-immunity in a mathematical model of tumor immunotherapy
    Forys, U
    Waniewski, J
    Zhivkov, P
    JOURNAL OF BIOLOGICAL SYSTEMS, 2006, 14 (01) : 13 - 30
  • [50] The cellular and molecular basis of CD69 function in anti-tumor immunity
    Koyama-Nasu, Ryo
    Wang, Yangsong
    Hasegawa, Ichita
    Endo, Yukihiro
    Nakayama, Toshinori
    Kimura, Motoko Y.
    INTERNATIONAL IMMUNOLOGY, 2022, 34 (11) : 555 - 561
12345